Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 27, 2015 - Issue 10
467
Views
18
CrossRef citations to date
0
Altmetric
Review Article

The transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system

, , &
Pages 451-461 | Received 27 Jan 2015, Accepted 03 Jul 2015, Published online: 24 Aug 2015

References

  • Abraham C, Cho JH. (2009). Inflammatory bowel disease. N Engl J Med 361:2066–78
  • Atarashi K, Tanoue T, Shima T, et al. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–41
  • Austrian R. (1968). The bacterial flora of the respiratory tract: some knowns and unknowns. Yale J Biol Med 40:400–13
  • Ayyobi F, Ghazanfari T, Askari N, et al. (2014). Chemokine (SDF-1α CXCL12) level in chemical veterans with pulmonary problems. Tebe Janbazan Military J 6:55–63
  • Azad MB, Kozyrskyj AL. (2012). Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol 2012:932072
  • Balali-Mood M, Hefazi M. (2006). Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–82
  • Barnes PJ. (2014). Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35:71–86
  • Beck JM, Young VB, Huffnagle GB. (2012). The microbiome of the lung. Transl Res 160:258–66
  • Beheshti J, Mark EJ, Akbaei HMH, et al. (2006). Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–44
  • Berger G, Wunderink RG. (2013). Lung microbiota: genuine or artifact? Isr Med Assoc J 15:731–3
  • Bourbeau J. (2009). Activities of life: the COPD patient. J Chron Obstruct Pulmon Dis 6:192–200
  • Bousbia S, Papazian L, Auffray JP, et al. (2010). Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis 16:258–63
  • Boyton RJ, Reynolds CJ, Quigley KJ, Altmann DM. (2013). Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exp Immunol 171:117–23
  • Brimfield AA, Soni SD, Trimmer KA, et al. (2012). Metabolic activation of sulfur mustard leads to oxygen free radical formation. Free Radic Biol Med 52:811–17
  • Chang C. (2012). Neonatal autoimmune diseases: a critical review. J Autoimmun 38:J223–38
  • Charlson ES, Bittinger K, Chen J, et al. (2012a). Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One 7:e42786
  • Charlson ES, Bittinger K, Haas AR, et al. (2011). Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184:957–63
  • Charlson ES, Diamond JM, Bittinger K, et al. (2012b). Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med 186:536–45
  • Chervonsky A. (2009). Innate receptors and microbes in induction of autoimmunity. Curr Opin Immunol 21:641–7
  • Cho I, Blaser MJ. (2012). The human microbiome: at the interface of health and disease. Nat Rev Genet 13:260–70
  • Collado MC, Bauerl C, Perez-Martinez G. (2012). Defining microbiota for developing new probiotics. Microb Ecol Health Dis 23:18579. doi: 10.3402/mehd.v23i0.18579
  • Derscheid RJ, Ackermann MR. (2013). The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection. Veterinary Pathol Online 50:827–41
  • Dickson RP, Erb-Downward JR, Huffnagle GB. (2013). The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7:245–57
  • Donnelly LE, Barnes PJ. (2012). Defective phagocytosis in airways diseasephagocytic dysfunction and airways disease. Chest J 141:1055–62
  • Duff RM, Simmonds NJ, Davies JC, et al. (2013). A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis. Eur Respir J 41:991–3
  • Ebrahimi M, Roudkenar MH, Fooladi I, et al. (2010). Discrepancy between mRNA and protein expression of neutrophil gelatinase-associated lipocalin in bronchial epithelium induced by sulfur mustard. J Biomed Biotechnol 2010:823131
  • Erb-Downward JR, Thompson DL, Han MK, et al. (2011). Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384
  • Fooladi AAI, Aghelimansour A, Nourani MR. (2013). Evaluation of the pathogenesis of Pseudomonas aeruginosa's flagellum before and after flagellar gene knockdown by small interfering RNAs (siRNA) 6:273–8
  • Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, et al. (2009). The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677–89
  • Garzoni C, Brugger SD, Qi W, et al. (2013). Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax 68:1150–6
  • Ghanei M, Shohrati M, Harandi AA, et al. (2007). Inhaled corticosteroids and long-acting β2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol 19:889–94
  • Ghasemi H, Ghazanfari T, Yaraee R, et al. (2009). Systemic and ocular complications of sulfur mustard: a panoramic review. Toxin Rev 28:14–23
  • Ghasemi H, Mostafaie A, Yaraee R, et al. (2013). Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study. Int Immunopharmacol 17:944–51
  • Ghazanfari T, Mostafaie A, Yaraee R, et al. (2013). Are serum levels of immunoglobulin classes and IgG subclasses involved in delayed pulmonary complications induced by sulfur mustard? Sardasht-Iran Cohort Study. Int Immunopharmacol 17:936–43
  • Ghazanfari T, Sharifnia Z, Yaraee R, et al. (2009). Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1489–93
  • Gollwitzer ES, Marsland BJ. (2014). Microbiota abnormalities in inflammatory airway diseases – potential for therapy. Pharmacol Ther 141:32–9
  • Gollwitzer ES, Saglani S, Trompette A, et al. (2014). Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med 20:642–7
  • Graham JS, Chilcott RP, Rice P, et al. (2005). Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 4:e1
  • Grice EA, Segre JA. (2012). The human microbiome: our second genome. Annu Rev Genom Hum Genet 13:151–70
  • Guandalini S, Cernat E, Moscoso D. (2015). Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Benef Microbes 6:209–17
  • Han MK, Huang YJ, Lipuma JJ, et al. (2012). Significance of the microbiome in obstructive lung disease. Thorax 67:456–63
  • Harris JK, De Groote MA, Sagel SD, et al. (2007). Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 104:20529–33
  • Hazebrouck S, Przybylski-Nicaise L, Ah-Leung S, et al. (2009). Allergic sensitization to bovine beta-lactoglobulin: comparison between germ-free and conventional BALB/c mice. Int Arch Allergy Immunol 148:65–72
  • Herbst T, Sichelstiel A, Schar C, et al. (2011). Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 184:198–205
  • Hilty M, Burke C, Pedro H, et al. (2010). Disordered microbial communities in asthmatic airways. PLoS One 5:e8578
  • Hodge S, Hodge G, Scicchitano R, et al. (2003). Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81:289–96
  • Holt PG, Upham JW, Sly PD. (2005). Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 116:16–24
  • Hooper LV, Gordon JI. (2001). Commensal host-bacterial relationships in the gut. Science 292:1115–18
  • Huang YJ, Charlson ES, Collman RG, et al. (2013). The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 187:1382–7
  • Huang YJ, Lynch SV. (2011). The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 5:809–21
  • Huang YJ, Nelson CE, Brodie EL, et al. (2011). Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127:372–81.e1–3
  • Huffnagle GB. (2010). The microbiota and allergies/asthma. PLoS Pathog 6:e1000549
  • Ichinohe T, Pang IK, Kumamoto Y, et al. (2011). Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 108:5354–9
  • Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, et al. (2013). Probiotic as a novel treatment strategy against liver disease. Hepat Mon 13:e7521
  • Imani Fooladi AA, Mousavi SF, Seghatoleslami S, et al. (2011). Toll-like receptors: role of inflammation and commensal bacteria. Inflamm Allergy Drug Targets 10:198–207
  • Imanifooladi AA, Yazdani S, Nourani MR. (2010). The role of nuclear factor-κB in inflammatory lung disease. Inflamm Allergy Drug Targets 9:197–205
  • Ivanov II, Atarashi K, Manel N, et al. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–98
  • Ivanov II, Frutos RDL, Manel N, et al. (2008). Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–49
  • Jafari M, Ghanei M. (2010). Evaluation of plasma, erythrocytes, and brochoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patients. Clin Toxicol 48:184–92
  • Kaplan JL, Shi HN, Walker WA. (2011). The role of microbes in developmental immunologic programming. Pediatr Res 69:465–72
  • Karadag F, Karul AB, Cildag O, et al. (2008). Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 186:403–9
  • Kehe K, Szinicz L. (2005). Medical aspects of sulphur mustard poisoning. Toxicology 214:198–209
  • Khani S, Hosseini HM, Taheri M, et al. (2012). Probiotics as an alternative strategy for prevention and treatment of human diseases: a review. Inflamm Allergy Drug Targets 11:79–89
  • Lari SM, Attaran D, Towhidi M. (2012). COPD due to sulfur mustard (mustard lung). Chronic Obstruct Pulmon Dis Curr Concepts Pract Croatia InTech 2:231–8
  • Lari SM, Ghobadi H, Attaran D, et al. (2014). COPD assessment test (CAT): simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease. Clin Respir J 8:116–23
  • Laurenzi GA, Potter RT, Kass EH. (1961). Bacteriologic flora of the lower respiratory tract. N Engl J Med 265:1273–8
  • Leme AS, Hubeau C, Xiang Y, et al. (2006). Role of breast milk in a mouse model of maternal transmission of asthma susceptibility. J Immunol 176:762–9
  • Littman DR, Pamer EG. (2011). Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 10:311–23
  • Liu L, Chen X, Skogerbø G, et al. (2012). The human microbiome: a hot spot of microbial horizontal gene transfer. Genomics 100:265–70
  • Lozupone C, Cota-Gomez A, Palmer BE, et al. (2013). Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 187:1110–17
  • Madan J, Koestler D, Stanton B, et al. (2012). Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 3:e00251–12
  • Malaviya R, Sunil VR, Cervelli J, et al. (2010). Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol 248:89–99
  • Marsland BJ, Yadava K, Nicod LP. (2013). The airway microbiome and disease. Chest 144:632–7
  • Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107–18
  • Mirzamani M, Zare S, Imanifooladi AA, Nourani MR. (2012). TGF-β gene expression in fibroblast cells of chemical veterans. Tebe Janbazan J 4:6–15
  • Moghadam KG, Keshmiri M, Omidi A-A, Tohidi M. (2003). Pulmonary complications of chemical warfare 15 years after exposure. Tanaffos 2:45–50
  • Monso E, Rosell A, Bonet G, et al. (1999). Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 13:338–42
  • Morris A, Beck JM, Schloss PD, et al. (2013). Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187:1067–75
  • Müllerova H, Chigbo C, Hagan GW, et al. (2012). The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med 106:1124–33
  • Murray PR, Rosenthal KS, Pfaller MA. (2013). Medical microbiology. 7th ed. Philadelphia: Elsevier/Saunders
  • Nourani M, Imanifooladi A, Yazdani S. (2011). Genome analysis of C-fos molecule after increasing free radicals in mustard exposed of airways of COPD paitents. Tebe Janbazan J 3:46–52
  • Nourani MR, Yazdani S, Roudkenar MH, et al. (2010). HO1 mRnA and protein do not change in parallel in bronchial biopsies of patients after long term exposure to sulfur mustard. Gene Regul Syst Biol 4:83–90
  • Ostman S, Rask C, Wold AE, et al. (2006). Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36:2336–46
  • Panahi Y, Ghaneei M, Aslani J, et al. (2004). Paper: Evaluation of microbial resistance to antibiotics in patients with chronic pulmonary lesions due to chemical agents and non-chemical agents. J Mil Med 6:181–6
  • Pecora DV. (1963). A comparison of transtracheal aspiration with other methods of determining the bacterial flora of the lower respiratory tract. N Engl J Med 269:664–6
  • Petersen C, Round JL. (2014). Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16:1024–33
  • Pirzad G, Jafari M, Tavana S, et al. (2011). The role of fas-fasl signaling pathway in induction of apoptosis in patients with sulfur mustard-induced chronic bronchiolitis. J Toxicol 2010:373612
  • Pourfarzam S, Ghazanfari T, Yaraee R, et al. (2009). Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1482–8
  • Prabhudas M, Adkins B, Gans H, et al. (2011). Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12:189–94
  • Pragman AA, Kim HB, Reilly CS, et al. (2012). The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305
  • Razavi SM, Salamati P, Harandi AA, Ghanei M. (2013). Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties. Int J Prev Med 4:383–9
  • Renz H, Brandtzaeg P, Hornef M. (2012). The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9–23
  • Risnes KR, Belanger K, Murk W, Bracken MB. (2010). Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol 173:310–18
  • Rogers GB, Van Der Gast CJ, Cuthbertson L, et al. (2013). Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68:731–7
  • Roshan R, Rahnama P, Ghazanfari Z, et al. (2013). Long-term effects of sulfur mustard on civilians’ mental health 20 years after exposure (The Sardasht-Iran Cohort Study). Health Qual Life Outcomes 11:69
  • Round JL, Mazmanian SK. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313–23
  • Sadraei S, Bahadoran H, Dashtnavard H, et al. (2011). Effect of sulfur mustard on the epithelial cell necrosis of urinary duct of kidney in rat. MilMed J 12:203–9
  • Salzman NH. (2011). Microbiota–immune system interaction: an uneasy alliance. Curr Opin Microbiol 14:99–105
  • Segal LN, Alekseyenko AV, Clemente JC, et al. (2013). Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1:19
  • Shaikh-Lesko R. (2014). Breathing life into lung microbiome research. The Scientist Magazine 9:1
  • Shams J, Ghazanfari T, Yaraee R, et al. (2009). Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Rev 28:39–43
  • Sharma AA, Jen R, Butler A, Lavoie PM. (2012). The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol 145:61–8
  • Shohrati M, Davoudi M, Ghanei M, et al. (2007). Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutaneous Ocular Toxicol 26:73–81
  • Smillie CS, Smith MB, Friedman J, et al. (2011). Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480:241–4
  • Stefanska AM, Walsh PT. (2009). Chronic obstructive pulmonary disease: evidence for an autoimmune component. Cell Mol Immunol 6:81–6
  • Steinritz D, Emmler J, Hintz M, et al. (2007). Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci 80:2199–201
  • Strunk T, Temming P, Gembruch U, et al. (2004). Differential maturation of the innate immune response in human fetuses. Pediatr Res 56:219–26
  • Sze MA, Dimitriu PA, Hayashi S, et al. (2012). The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1073–80
  • Sze MA, Hogg JC, Sin DD. (2014). Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis 9:229–38
  • Taylor A, Finney-Hayward T, Quint J, et al. (2010). Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 35:1039–47
  • Thaiss CA, Levy M, Suez J, Elinav E. (2014). The interplay between the innate immune system and the microbiota. Curr Opin Immunol 26:41–8
  • Turnbaugh PJ, Ley RE, Hamady M, et al. (2007). The human microbiome project. Nature 449:804–10
  • Ubeda C, Pamer EG. (2012). Antibiotics, microbiota, and immune defense. Trends Immunol 33:459–66
  • Ursell LK, Metcalf JL, Parfrey LW, Knight R. (2012). Defining the human microbiome. Nutr Rev 70:S38–44
  • Vieira LQ, Oliveira MR, Neumann E, et al. (1998). Parasitic infections in germfree animals. Braz J Med Biol Res 31:105–10
  • Williams AE. (2011). Immunology: mucosal and body surface defences. Oxford: Wiley-Blackwell
  • Worbs T, Bode U, Yan S, et al. (2006). Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 203:519–27
  • Yaraee R, Ghazanfari T, Ebtekar M, et al. (2009). Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1466–70
  • Yi P, Li L. (2012). The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Vet Microbiol 157:1–7
  • Zakharkina T, Heinzel E, Koczulla RA, et al. (2013). Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing. PLoS One 8:e68302
  • Zarin AA, Behmanesh M, Tavallaei M, et al. (2010). Overexpression of transforming growth factor (TGF)-β1 and TGF-β3 genes in lung of toxic-inhaled patients. Exp Lung Res 36:284–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.